N

NovaBay Pharmaceuticals
D

NBY

0.56230
USD
-0.02
(-3.88%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
3,270,452
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.670 USD
AZN
AZN
1.720
(2.38%)
73.950 USD
GSK
GSK
1.345
(3.57%)
38.980 USD
JNJ
JNJ
4.470
(2.88%)
159.810 USD
MRK
MRK
-0.220
(-0.25%)
86.370 USD
NVS
NVS
1.540
(1.39%)
112.300 USD
PFE
PFE
-0.385
(-1.56%)
24.290 USD
P
PLX
0.01000
(0.39%)
2.60000 USD
SNY
SNY
0.720
(1.34%)
54.610 USD
المزيد
الأخبار المقالات

العنوان: NovaBay Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratorytested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.